These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2210813

  • 41. Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria.
    Ruilope LM, Miranda B, Oliet A, Millet VG, Rodicio JL, Romero JC, Raij L.
    J Hypertens Suppl; 1988 Dec; 6(4):S467-9. PubMed ID: 3071587
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS.
    Kidney Int Suppl; 1996 Dec; 57():S132-6. PubMed ID: 8941934
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
    Wilson TW, Alonso-Galicia M, Roman RJ.
    Hypertension; 1998 Jan; 31(1 Pt 2):225-31. PubMed ID: 9453307
    [Abstract] [Full Text] [Related]

  • 46. Captopril and time dependent changes in post- to pre-glomerular resistance ratios in remnant kidneys of pre-hypertensive rats.
    Wilke WL, Persson AE.
    Acta Physiol Scand; 1992 Mar; 144(3):253-61. PubMed ID: 1585810
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G.
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass.
    Larivière R, Lebel M, Kingma I, Grose JH, Boucher D.
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):989-97. PubMed ID: 9715793
    [Abstract] [Full Text] [Related]

  • 53. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure.
    Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A.
    Kidney Int; 1992 Jul; 42(1):46-55. PubMed ID: 1635354
    [Abstract] [Full Text] [Related]

  • 54. Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency.
    Meyer TW, Anderson S, Rennke HG, Brenner BM.
    Am J Med; 1985 Sep 27; 79(3C):31-6. PubMed ID: 2996344
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effects of antihypertensive agents on blood pressure and the progress of renal failure in partially nephrectomized spontaneously hypertensive rats.
    Katsumata H, Suzuki H, Ohishi A, Nakamoto H, Saruta T, Sakaguchi H.
    Lab Invest; 1990 Apr 27; 62(4):474-80. PubMed ID: 2185377
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Beneficial effect of the long-term treatment with the combination of an ACE inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy.
    Flores O, Arévalo M, Gallego B, Hidalgo F, Vidal S, López-Novoa JM.
    Exp Nephrol; 1998 Apr 27; 6(1):39-49. PubMed ID: 9523172
    [Abstract] [Full Text] [Related]

  • 59. Reversing glomerular hypertension stabilizes established glomerular injury.
    Meyer TW, Anderson S, Rennke HG, Brenner BM.
    Kidney Int; 1987 Mar 27; 31(3):752-9. PubMed ID: 3033388
    [Abstract] [Full Text] [Related]

  • 60. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
    Raij L, Chiou XC, Owens R, Wrigley B.
    Am J Med; 1985 Sep 27; 79(3C):37-41. PubMed ID: 2996345
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.